Economy

Billion Dollar Payout Ends Long Legal Battle Over Glyphosate Safety

Bayer has reached a massive nationwide settlement to compensate thousands of individuals who allege that the weed killer Roundup caused them to develop non Hodgkin lymphoma. A judge in Missouri gave final approval to the deal on Friday, paving the way for payouts that could cost the agrochemical giant up to 7.25 billion dollars over several years. Depending on their level of exposure and diagnosis age, claimants may receive payments ranging from 10,000 to 165,000 dollars.

For Bayer CEO Bill Anderson, the agreement represents a decisive milestone intended to mitigate the financial risks associated with ongoing and future litigation. Judge Timothy Boyer noted that this particular arrangement ranks among the largest mass tort personal injury settlements in history. This move follows a separate earlier agreement where Bayer committed between 10 billion and 11 billion dollars to resolve over 100,000 similar claims against the company.

Despite these staggering sums, Bayer continues to deny that glyphosate causes cancer. While the World Health Organization once labeled the chemical as probably carcinogenic and many environmental scientists agree, the Environmental Protection Agency has previously stated it found no concerning risks regarding cancer. The EPA is currently reviewing health evidence again following significant pressure from public health advocates.

The legal battle exists within a complex political landscape where recent government actions have favored the manufacturer. Although residents can no longer buy glyphosate based products for home use in the U.S., it remains staples in industrial agriculture. Even as figures like Robert F Kennedy Junior push for stricter regulations under a healthy living agenda, the current administration has supported Bayer through Supreme Court filings and orders promoting domestic production of the herbicide.